Skip to Main Content Area
  • ABOUT
  • CONTACT
  • ADVERTISE
Home
  • Home
  • News
  • Meeting Coverage
    • 2011 ASCO Annual Meeting
  • Continuing Education
  • Supplements
  • Issue Archive
  • Editorial Board
  • Subscribe

Supplements

Risk Management: A new Era of Patient Safety
Advances in Treatment Options and Management of Chemotherapy-induced Nausea and Vomiting
Cutaneous and Peripheral T-Cell Lymphomas: The Latest in Treatment Advances and Management Strategies
ASH Highlights on Non-Hodgkin Lymphoma: A Payer's and Pharmacist's Perspective
Considerations in Non-Hodgkin's Lymphoma: Clinical Trial Updates
Considerations in Non-Hodgkin's Lymphoma: T-Cell Lymphomas
Conference Faculty Perspectives: Compendium From ASH, the XII International Myeloma Workshop, and the Pan Pacific Lymphoma Conference
Considerations in Non-Hodgkin's Lymphoma: Diffuse Large B-Cell Lymphoma
Conference Faculty Perspectives: Updates From the Pan Pacific Lymphoma Conference
Considerations in Non-Hodgkin's Lymphoma: Waldenstrom's Macroglobulinemia
  • 1
  • 2
  • 3
  • next ›
  • last »

Reader Poll

How important is your knowledge of J-Codes to your practice as an oncology pharmacist?:

Top 5 Most Read Articles

  • Voraxaze Approved by FDA to Lower High Blood Levels of Chemotherapy
  • New Breast Cancer Treatment Model Emerging as Standard of Care
  • FDA Issues New Boxed Warning and Contraindication for Adcetris
  • Parabens Discovered in Breast Tissue Samples
  • Highly Accurate New Test for Colorectal Cancer
Terms of Use • Copyright © 2008-2011 Greenhill Healthcare Communications, LLC. All rights reserved. • Privacy Policy
241 Forsgate Drive, Suite 205C, Monroe Township, NJ 08831